Rogers Corporation 2017 Form 10-K Summary
Business Context and Reporting Period
Rogers Corporation designs and manufactures engineered materials and components for mission-critical applications. Its principal segments are Advanced Connectivity Solutions (ACS), Elastomeric Material Solutions (EMS), and Power Electronics Solutions (PES), with remaining activities reported as Other. The filing covers the fiscal year ended December 31, 2017; fourth-quarter net sales were $209.0 million and net income was $7.0 million.
Growth priorities include advanced connectivity, advanced mobility, automotive radar, electric and hybrid vehicles, next-generation wireless infrastructure, renewable energy, aerospace and defense, and industrial applications. Rogers acquired Diversified Silicone Products (DSP) in January 2017 and integrated it into EMS; DeWAL, acquired in November 2016, also contributed materially to 2017 results.
Financial Performance, Cash Flow, Debt and Liquidity
| Metric | 2017 | 2016 | Change |
|---|---|---|---|
| Net sales | $821.0 million | $656.3 million | 25.1% increase |
| Gross margin | 38.8% | 38.0% | Up 79 basis points |
| Operating income | $130.8 million | $83.9 million | 56.0% increase |
| Operating margin | 15.9% | 12.8% | Up 315 basis points |
| Income before taxes | $132.9 million | $82.3 million | 61.6% increase |
| Net income | $80.5 million | $48.3 million | 66.6% increase |
| Diluted EPS | $4.34 | $2.65 | 63.8% increase |
| Operating cash flow | $139.0 million | $117.0 million | 18.8% increase |
| Capital expenditures | $27.2 million | $18.1 million | Increase |
Segment sales were ACS $301.1 million, EMS $312.7 million, PES $185.0 million, and Other $22.3 million. Segment operating income was $56.2 million, $51.4 million, $16.0 million, and $7.2 million, respectively. EMS was the largest growth contributor, with sales up 53.9% and operating income up 93.3%, driven by acquisitions and organic demand. PES sales rose 21.4%, while ACS sales rose 8.4%.
Cash and cash equivalents were $181.2 million at year-end, down from $227.8 million. The decline primarily reflected $110.2 million of discretionary debt repayments, the $60.2 million DSP acquisition, and $27.2 million of capital expenditures. Current assets were $454.5 million versus current liabilities of $113.8 million, representing a 4.0-to-1 current ratio. Net working capital was $340.7 million.
Outstanding credit-facility borrowings declined to $131.0 million from $235.9 million. The refinanced revolving facility provides up to $450.0 million of borrowing capacity plus a $175.0 million accordion feature and matures February 17, 2022. The effective all-in interest rate at year-end was 2.945%. A 100-basis-point increase in LIBOR would increase annual interest expense by approximately $1.3 million based on year-end borrowings.
Research and development expense was $29.5 million, or 3.6% of sales. Firm backlog was $122.8 million at year-end, compared with $106.5 million in 2016, and was expected to be fulfilled within 12 months. No dividends were paid, and management did not anticipate paying cash dividends in the foreseeable future. No shares were repurchased in 2017; $52.0 million remained under the repurchase authorization.
Material Changes, Outlook and Unusual Items
- Revenue growth reflected both acquisitions and organic growth across ACS, EMS, and PES. The company attributed margin expansion to higher utilization, automation, process improvements, low-cost-country manufacturing, and acquisition synergies.
- 2017 included $3.4 million of restructuring and impairment charges, including headquarters relocation costs, an investment impairment, and a PES intangible-asset impairment. Gains of approximately $5.3 million were recognized on sales of Belgian property.
- The effective tax rate was 39.5%, including a provisional $13.7 million charge related to the U.S. Tax Cuts and Jobs Act. Excluding U.S. tax reform, management reported a 29.2% effective tax rate. The tax reform amounts remained subject to further analysis and potential adjustment in 2018.
- Management expected 2018 capital expenditures of approximately $50 million to $60 million, funded with operating cash flow. The filing states that available liquidity and expected operating cash flow should fund operations, capital expenditures, research and development, debt service, and other needs for at least the next 12 months.
- Management intends to terminate a merged defined-benefit pension plan, subject to IRS approval, with settlement expected in late 2018 or early 2019. The filing does not provide a clear estimate of the resulting financial impact.
- Asbestos-related cases increased to 687 from 605. Projected liability through 2058 was $76.2 million, with estimated insurance recovery of $69.2 million; the company recorded approximately $7.0 million of net estimated exposure. Management warned that actual costs and recoveries could differ materially.
- Foreign markets represented approximately 71% of sales, including approximately 48% in Asia and 22% in Europe. Foreign exchange, international economic conditions, tariffs and trade restrictions, supply disruptions, competition, technology adoption, cybersecurity, environmental matters, and litigation remain key risks.
- The company planned to adopt the new revenue-recognition standard using the modified retrospective method on January 1, 2018. It estimated an approximately $4.0 million, net-of-tax increase to retained earnings, primarily from recognizing certain revenue over time.
Most Important Facts for Investors to Verify
- Assess how much of 2017 growth was organic versus attributable to DeWAL and DSP, particularly within EMS.
- Monitor whether improved gross and operating margins are sustainable after acquisition integration, restructuring, and property-sale gains.
- Review the provisional $13.7 million tax-reform charge and any 2018 adjustments, including impacts from GILTI, BEAT, and foreign cash deployment.
- Verify debt covenant compliance, refinancing terms, variable-rate exposure, and the February 2022 maturity.
- Evaluate cash availability because approximately $145.5 million of year-end cash was held by non-U.S. subsidiaries and may face additional tax or repatriation restrictions.
- Track asbestos claims, insurance recoverability, environmental remediation, and the proposed pension-plan termination.
- Examine the expected $50 million to $60 million of 2018 capital spending and its effect on free cash flow and debt reduction.
- Consider concentration in international markets and exposure to automotive, telecommunications, renewable energy, consumer electronics, and other cyclical end markets.